Stay updated on Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedAdded Hepatocellular carcinoma as a study topic and linked the Genetic and Rare Diseases Information Center as a resources reference. Updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; the new revision notice shows Revision: v3.4.2 and replaces the previous Revision: v3.4.1.SummaryDifference0.0%

- Check44 days agoChange DetectedFooter/site revision updated from v3.4.0 to v3.4.1; no changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check51 days agoChange DetectedShow glossary feature added; page metadata labels updated (Last Update Submitted that Met QC Criteria and No FEAR Act Data); revision bumped to v3.4.0. These are UI/metadata refinements and do not alter core study information, eligibility criteria, endpoints, or results.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.3.4 added and Revision: v3.3.3 removed as part of a backend update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.